Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that it will present at the at the upcoming Noble Financial Fourth Annual Equity Conference which will be held Monday, August 18^th - Tuesday, August 19^th, 2008 at the Loews Lake Las Vegas Resort, NV. Drew Fromkin, President and Chief Executive Officer will discuss the Company’s business strategy and historical financial performance at 1:30 p.m. Pacific Time on Monday, August 18^th.

A live audio webcast of Clinical Data’s presentation may be accessed through the Company’s website at www.clda.com. An archived replay of the presentation will be available after the live presentation, and can also be accessed at www.clda.com.

About Clinical Data, Inc.

Clinical Data, Inc. is unlocking the potential of molecular discovery from Targeted Science to Better Healthcare™. Its PGxHealth^® division focuses on proprietary biomarker and pharmacogenetic test development as well as targeted therapeutics to help predict drug safety and efficacy, thereby reducing health care costs and improving clinical outcomes. Its Cogenics^® division provides genomics services to both research and regulated environments. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. Visit the Company's website at www.clda.com for more information.

EVC Group, Inc.
Dahlia Bailey, +1-415-896-5862 (investors)
Steve DiMattia, +1-646-201-5445 (media)
Chris Gale, +1-646-201-5431 (media)